… bars), identified using ‘antiarrhythmic drugs’ AND ‘atrial fibrillation’, and those not … (‘atrial
fibrillation’ AND ‘antiarrhythmic drugs’) shown in green bars, or AF and ablation (‘atrial fibrillation…

… We focus on the basic and clinical pharmacology of newly emerging antiarrhythmic drugs
and non-traditional approaches such as upstream therapy for atrial fibrillation. …

… Despite these limitations, antiarrhythmic drugs remain widely … antiarrhythmic drugs are in
various stages of clinical development. This review will focus primarily on antiarrhythmic drug …

… Finally, we critically appraise emerging antiarrhythmic drug principles and future directions
for antiarrhythmic drug development, as well as their potential for improving AF management. …

Atrial fibrillation (AF) is the most common arrhythmia, and its incidence increases with advanced
age. About 1% of patients with AF are younger than 60 years, 12% are between 75 and …

… Oral antiarrhythmic drugs used for atrial fibrillation: clinical … of using type iC antiarrhythmic
drugs for the the treatment o fatrial fibrillation, ~~~~treatment of paroxysmal atrial fibrillation. …

… Quinidine is a long-established antiarrhythmic drug which is now no longer being produced,
although its unique efficacy in treating some inherited causes of arrhythmia may result in …

The recent Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial [1]
has led to a fundamental change in the therapeutic approach to patients with atrial …

… drugs, such as β-blockers or L-type calcium channel blockers. In patients in whom rate control
is insufficient, antiarrhythmic drugs (… no mortality benefit of antiarrhythmic-derived rhythm …

… The aim of the study was to assess and compare the safety of antiarrhythmic drugs (AADs)
in an unselected real-world population of patients with atrial fibrillation (AF). …